ADUS Stock Analysis: Buy, Sell, or Hold?
ADUS - Addus HomeCare Corp.
$95.03
0.80 (0.85%)
▲
5d:
+1.88%
30d:
+1.35%
90d:
-4.28%
BUY
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 03, 2026
Get Alerted When ADUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ADUS shows positive signals but monitor for confirmation. Market pricing in 3.7% decline. Moderate conviction.
💡 BUY OPPORTUNITY: ADUS shows positive signals but monitor for confirmation. Market pricing in 3.7% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$139.30
Based on 5.5% avg growth
INTRINSIC VALUE TODAY
$86.50
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ADUS is currently trading at $95.03, which is considered extended relative to its 30-day fair value range of $90.86 to $94.27. From a valuation perspective, the stock is trading at a discount (Forward PE: 12.7) compared to its historical average (14.3). Remarkably, the market is currently pricing in an annual earnings decline of 3.7% over the next few years. This pessimistic expectation contrasts with the company's recent 17.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ADUS is in a strong downtrend. The price is approaching resistance at $97.26. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ADUS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $132.69 (+39.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ADUS is in a strong downtrend. The price is approaching resistance at $97.26. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ADUS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $132.69 (+39.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$90.86 -
$94.27
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 39.6% below Wall St target ($132.69)
Trading Range Analysis
30-Day Trading Range
$90.86 -
$94.27
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$90.53
Resistance Level
$97.26
Current Trend
Strong Downtrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.72
Wall Street Target
$132.69
(+39.6%)
Revenue Growth (YoY)
7.7%
Earnings Growth (YoY)
17.2%
Profit Margin
6.9%
Valuation Discount vs History
-3.7% cheaper
PE vs Historical
12.7 vs 14.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.7%
(market-implied from PE analysis)
1-Year Target
$91.51
(-4%)
2-Year Target
$88.13
(-7%)
3-Year Target
$84.87
(-11%)
3-Yr Target (if PE normalizes)
(PE: 13→14)
$95.43
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 6.9%)
$199.06
(+110%)
Base:
(SPY PE: 12.7, Growth: 6.9%)
$116.23
(+22%)
Bear:
(PE: 10.8, Growth: 6.9%)
$98.79
(+4%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 17.39 | Current EPS (TTM): $5.42
Bull Case
$142.91
(+50%)
Analyst growth 37.9%, PE expands to 19.1
Base Case
$129.92
(+37%)
Market implied 37.9%, PE stable at 17.4
Bear Case
$64.08
(-33%)
Severe decline -20.0%, PE contracts to 14.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.7 to 14.3
Stabilization Target:
$106.86
(+12.5%)
PE Expansion Potential:
+12.5%
Share & Embed Analysis
Last updated: June 23, 2026 6:54 AM ET
Data refreshes hourly during market hours. Next update: 7:54 AM
Data refreshes hourly during market hours. Next update: 7:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADUS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
19
Sells
Net
INSIDERS SELLING
Recent Transactions
Cliff Donald Blessing
SELL
178 shares
2026-04-21
Brian Poff
SELL
820 shares
2026-02-25
Cliff Donald Blessing
SELL
177 shares
2026-02-25
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$504 | 60 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 53 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 54 HOLD |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 62 BUY |
